The Medicines Company Announces FDA Approval of KENGREAL as an Adjunct to Percutaneous Coronary Intervention for Reducing Thrombotic Events
June 22, 2015 at 15:06 PM EDT
The Medicines Company (NASDAQ: MDCO) today announced the approval of KENGREAL(TM) (cangrelor) by the U.S. Food and Drug Administration ...